Will Sociogenomics Reduce Social Inequality?
By Erik Parens,
The Hastings Center
| 09. 30. 2021
In her new book, Kathryn Paige Harden is full of hope that insights from genetics will become powerful tools for advancing a left-leaning political agenda. Her hope rests on the argument that if people understand the extent to which their socioeconomic status is influenced by their luck in the genetic lottery, they will understand that they do not merit that status and will become committed to social policies that favor redistributing resources. That is, she hopes the field of sociogenomics, in which social scientists use genetic data to predict outcomes as complex as educational attainment, will be used—not to justify—but to reduce social inequality.
Moreover, Harden is full of enthusiasm about the potential of sociogenomics for creating concrete social interventions that can reduce social inequality. Her enthusiasm rests on the argument that, if social scientists begin to control for genetics when they seek to understand social outcomes, they can start to create social interventions that actually work and contribute to reducing the obscene inequalities that plague our society. Not only is Harden, a behavior geneticist and psychologist at...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...